nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolasetron—CYP2C9—Leflunomide—systemic scleroderma	0.124	0.423	CbGbCtD
Dolasetron—CYP2D6—Captopril—systemic scleroderma	0.0893	0.304	CbGbCtD
Dolasetron—HTR3A—myenteric nerve plexus—systemic scleroderma	0.0587	0.479	CbGeAlD
Dolasetron—CYP2C9—cardial valve—systemic scleroderma	0.0503	0.41	CbGeAlD
Dolasetron—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0447	0.152	CbGbCtD
Dolasetron—CYP3A4—Prednisone—systemic scleroderma	0.0357	0.121	CbGbCtD
Dolasetron—HTR3A—digestive system—systemic scleroderma	0.00444	0.0362	CbGeAlD
Dolasetron—HTR3A—lung—systemic scleroderma	0.00371	0.0303	CbGeAlD
Dolasetron—CYP2C9—digestive system—systemic scleroderma	0.00218	0.0178	CbGeAlD
Dolasetron—CYP3A4—digestive system—systemic scleroderma	0.00166	0.0135	CbGeAlD
Dolasetron—CYP2D6—digestive system—systemic scleroderma	0.00163	0.0133	CbGeAlD
Dolasetron—Cough—Lisinopril—systemic scleroderma	0.000652	0.00112	CcSEcCtD
Dolasetron—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.00065	0.00111	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000647	0.00111	CcSEcCtD
Dolasetron—Anorexia—Mycophenolic acid—systemic scleroderma	0.000646	0.00111	CcSEcCtD
Dolasetron—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000645	0.00111	CcSEcCtD
Dolasetron—Abdominal distension—Prednisone—systemic scleroderma	0.000641	0.0011	CcSEcCtD
Dolasetron—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000641	0.0011	CcSEcCtD
Dolasetron—Paraesthesia—Leflunomide—systemic scleroderma	0.000637	0.00109	CcSEcCtD
Dolasetron—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.000636	0.00109	CcSEcCtD
Dolasetron—Arthralgia—Lisinopril—systemic scleroderma	0.000636	0.00109	CcSEcCtD
Dolasetron—Myalgia—Lisinopril—systemic scleroderma	0.000636	0.00109	CcSEcCtD
Dolasetron—Chest pain—Lisinopril—systemic scleroderma	0.000636	0.00109	CcSEcCtD
Dolasetron—Anxiety—Lisinopril—systemic scleroderma	0.000634	0.00109	CcSEcCtD
Dolasetron—Dyspnoea—Leflunomide—systemic scleroderma	0.000633	0.00109	CcSEcCtD
Dolasetron—Hypotension—Mycophenolic acid—systemic scleroderma	0.000633	0.00109	CcSEcCtD
Dolasetron—Discomfort—Lisinopril—systemic scleroderma	0.000629	0.00108	CcSEcCtD
Dolasetron—Dyspepsia—Leflunomide—systemic scleroderma	0.000625	0.00107	CcSEcCtD
Dolasetron—Pancreatitis—Prednisone—systemic scleroderma	0.000625	0.00107	CcSEcCtD
Dolasetron—Dry mouth—Lisinopril—systemic scleroderma	0.000622	0.00107	CcSEcCtD
Dolasetron—Sweating increased—Prednisone—systemic scleroderma	0.000621	0.00106	CcSEcCtD
Dolasetron—Feeling abnormal—Azathioprine—systemic scleroderma	0.000619	0.00106	CcSEcCtD
Dolasetron—Rash—Mometasone—systemic scleroderma	0.000618	0.00106	CcSEcCtD
Dolasetron—Asthenia—Captopril—systemic scleroderma	0.000618	0.00106	CcSEcCtD
Dolasetron—Dermatitis—Mometasone—systemic scleroderma	0.000618	0.00106	CcSEcCtD
Dolasetron—Decreased appetite—Leflunomide—systemic scleroderma	0.000617	0.00106	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000617	0.00106	CcSEcCtD
Dolasetron—Confusional state—Lisinopril—systemic scleroderma	0.000615	0.00105	CcSEcCtD
Dolasetron—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000615	0.00105	CcSEcCtD
Dolasetron—Headache—Mometasone—systemic scleroderma	0.000614	0.00105	CcSEcCtD
Dolasetron—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000614	0.00105	CcSEcCtD
Dolasetron—Fatigue—Leflunomide—systemic scleroderma	0.000612	0.00105	CcSEcCtD
Dolasetron—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00061	0.00105	CcSEcCtD
Dolasetron—Oedema—Lisinopril—systemic scleroderma	0.00061	0.00105	CcSEcCtD
Dolasetron—Pruritus—Captopril—systemic scleroderma	0.000609	0.00104	CcSEcCtD
Dolasetron—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000608	0.00104	CcSEcCtD
Dolasetron—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000608	0.00104	CcSEcCtD
Dolasetron—Pain—Leflunomide—systemic scleroderma	0.000607	0.00104	CcSEcCtD
Dolasetron—Constipation—Leflunomide—systemic scleroderma	0.000607	0.00104	CcSEcCtD
Dolasetron—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000605	0.00104	CcSEcCtD
Dolasetron—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000604	0.00104	CcSEcCtD
Dolasetron—Somnolence—Mycophenolic acid—systemic scleroderma	0.000602	0.00103	CcSEcCtD
Dolasetron—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000602	0.00103	CcSEcCtD
Dolasetron—Shock—Lisinopril—systemic scleroderma	0.0006	0.00103	CcSEcCtD
Dolasetron—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000598	0.00103	CcSEcCtD
Dolasetron—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000597	0.00102	CcSEcCtD
Dolasetron—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000596	0.00102	CcSEcCtD
Dolasetron—Tachycardia—Lisinopril—systemic scleroderma	0.000595	0.00102	CcSEcCtD
Dolasetron—Abdominal pain—Azathioprine—systemic scleroderma	0.000594	0.00102	CcSEcCtD
Dolasetron—Body temperature increased—Azathioprine—systemic scleroderma	0.000594	0.00102	CcSEcCtD
Dolasetron—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000591	0.00101	CcSEcCtD
Dolasetron—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00059	0.00101	CcSEcCtD
Dolasetron—Diarrhoea—Captopril—systemic scleroderma	0.000589	0.00101	CcSEcCtD
Dolasetron—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000589	0.00101	CcSEcCtD
Dolasetron—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000588	0.00101	CcSEcCtD
Dolasetron—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000587	0.00101	CcSEcCtD
Dolasetron—Feeling abnormal—Leflunomide—systemic scleroderma	0.000585	0.001	CcSEcCtD
Dolasetron—Fatigue—Mycophenolic acid—systemic scleroderma	0.000584	0.001	CcSEcCtD
Dolasetron—Anorexia—Lisinopril—systemic scleroderma	0.000581	0.000997	CcSEcCtD
Dolasetron—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00058	0.000995	CcSEcCtD
Dolasetron—Ataxia—Methotrexate—systemic scleroderma	0.000579	0.000993	CcSEcCtD
Dolasetron—Pain—Mycophenolic acid—systemic scleroderma	0.000579	0.000993	CcSEcCtD
Dolasetron—Constipation—Mycophenolic acid—systemic scleroderma	0.000579	0.000993	CcSEcCtD
Dolasetron—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000579	0.000992	CcSEcCtD
Dolasetron—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000576	0.000987	CcSEcCtD
Dolasetron—Cough—Mycophenolate mofetil—systemic scleroderma	0.000571	0.00098	CcSEcCtD
Dolasetron—Hypotension—Lisinopril—systemic scleroderma	0.00057	0.000977	CcSEcCtD
Dolasetron—Dizziness—Captopril—systemic scleroderma	0.00057	0.000977	CcSEcCtD
Dolasetron—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000567	0.000973	CcSEcCtD
Dolasetron—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000565	0.000969	CcSEcCtD
Dolasetron—Urticaria—Leflunomide—systemic scleroderma	0.000564	0.000967	CcSEcCtD
Dolasetron—Body temperature increased—Leflunomide—systemic scleroderma	0.000561	0.000962	CcSEcCtD
Dolasetron—Abdominal pain—Leflunomide—systemic scleroderma	0.000561	0.000962	CcSEcCtD
Dolasetron—Acute coronary syndrome—Prednisone—systemic scleroderma	0.00056	0.00096	CcSEcCtD
Dolasetron—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000558	0.000957	CcSEcCtD
Dolasetron—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000557	0.000956	CcSEcCtD
Dolasetron—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000557	0.000956	CcSEcCtD
Dolasetron—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000557	0.000956	CcSEcCtD
Dolasetron—Myocardial infarction—Prednisone—systemic scleroderma	0.000557	0.000955	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000556	0.000953	CcSEcCtD
Dolasetron—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000556	0.000953	CcSEcCtD
Dolasetron—Hypersensitivity—Azathioprine—systemic scleroderma	0.000554	0.00095	CcSEcCtD
Dolasetron—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000554	0.00095	CcSEcCtD
Dolasetron—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000551	0.000944	CcSEcCtD
Dolasetron—Paraesthesia—Lisinopril—systemic scleroderma	0.000548	0.000939	CcSEcCtD
Dolasetron—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000545	0.000935	CcSEcCtD
Dolasetron—Dyspnoea—Lisinopril—systemic scleroderma	0.000544	0.000932	CcSEcCtD
Dolasetron—Rash—Captopril—systemic scleroderma	0.000543	0.000931	CcSEcCtD
Dolasetron—Dermatitis—Captopril—systemic scleroderma	0.000543	0.00093	CcSEcCtD
Dolasetron—Somnolence—Lisinopril—systemic scleroderma	0.000542	0.00093	CcSEcCtD
Dolasetron—Headache—Captopril—systemic scleroderma	0.00054	0.000925	CcSEcCtD
Dolasetron—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000539	0.000924	CcSEcCtD
Dolasetron—Dyspepsia—Lisinopril—systemic scleroderma	0.000537	0.000921	CcSEcCtD
Dolasetron—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000535	0.000918	CcSEcCtD
Dolasetron—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000535	0.000918	CcSEcCtD
Dolasetron—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000534	0.000916	CcSEcCtD
Dolasetron—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000534	0.000916	CcSEcCtD
Dolasetron—Decreased appetite—Lisinopril—systemic scleroderma	0.00053	0.000909	CcSEcCtD
Dolasetron—Fatigue—Lisinopril—systemic scleroderma	0.000526	0.000902	CcSEcCtD
Dolasetron—Shock—Mycophenolate mofetil—systemic scleroderma	0.000526	0.000902	CcSEcCtD
Dolasetron—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000523	0.000897	CcSEcCtD
Dolasetron—Hypersensitivity—Leflunomide—systemic scleroderma	0.000523	0.000897	CcSEcCtD
Dolasetron—Pancreatitis—Methotrexate—systemic scleroderma	0.000522	0.000895	CcSEcCtD
Dolasetron—Pain—Lisinopril—systemic scleroderma	0.000522	0.000894	CcSEcCtD
Dolasetron—Constipation—Lisinopril—systemic scleroderma	0.000522	0.000894	CcSEcCtD
Dolasetron—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000522	0.000894	CcSEcCtD
Dolasetron—Bradycardia—Prednisone—systemic scleroderma	0.000519	0.00089	CcSEcCtD
Dolasetron—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000517	0.000886	CcSEcCtD
Dolasetron—Diarrhoea—Azathioprine—systemic scleroderma	0.000514	0.000882	CcSEcCtD
Dolasetron—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000509	0.000873	CcSEcCtD
Dolasetron—Asthenia—Leflunomide—systemic scleroderma	0.000509	0.000873	CcSEcCtD
Dolasetron—Feeling abnormal—Lisinopril—systemic scleroderma	0.000503	0.000862	CcSEcCtD
Dolasetron—Pruritus—Leflunomide—systemic scleroderma	0.000502	0.000861	CcSEcCtD
Dolasetron—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000499	0.000856	CcSEcCtD
Dolasetron—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000499	0.000855	CcSEcCtD
Dolasetron—Dysuria—Methotrexate—systemic scleroderma	0.000498	0.000854	CcSEcCtD
Dolasetron—Dizziness—Azathioprine—systemic scleroderma	0.000497	0.000852	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000487	0.000835	CcSEcCtD
Dolasetron—Asthenia—Mycophenolic acid—systemic scleroderma	0.000486	0.000833	CcSEcCtD
Dolasetron—Diarrhoea—Leflunomide—systemic scleroderma	0.000486	0.000833	CcSEcCtD
Dolasetron—Urticaria—Lisinopril—systemic scleroderma	0.000485	0.000831	CcSEcCtD
Dolasetron—Abdominal pain—Lisinopril—systemic scleroderma	0.000482	0.000827	CcSEcCtD
Dolasetron—Body temperature increased—Lisinopril—systemic scleroderma	0.000482	0.000827	CcSEcCtD
Dolasetron—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00048	0.000823	CcSEcCtD
Dolasetron—Pruritus—Mycophenolic acid—systemic scleroderma	0.000479	0.000822	CcSEcCtD
Dolasetron—Pneumonia—Methotrexate—systemic scleroderma	0.000477	0.000819	CcSEcCtD
Dolasetron—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000476	0.000817	CcSEcCtD
Dolasetron—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000475	0.000815	CcSEcCtD
Dolasetron—Drowsiness—Methotrexate—systemic scleroderma	0.000475	0.000814	CcSEcCtD
Dolasetron—Rash—Azathioprine—systemic scleroderma	0.000474	0.000813	CcSEcCtD
Dolasetron—Dermatitis—Azathioprine—systemic scleroderma	0.000474	0.000812	CcSEcCtD
Dolasetron—Flushing—Prednisone—systemic scleroderma	0.000473	0.000811	CcSEcCtD
Dolasetron—Headache—Azathioprine—systemic scleroderma	0.000471	0.000807	CcSEcCtD
Dolasetron—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00047	0.000807	CcSEcCtD
Dolasetron—Dizziness—Leflunomide—systemic scleroderma	0.000469	0.000805	CcSEcCtD
Dolasetron—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000465	0.000797	CcSEcCtD
Dolasetron—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000463	0.000794	CcSEcCtD
Dolasetron—Stomatitis—Methotrexate—systemic scleroderma	0.000463	0.000793	CcSEcCtD
Dolasetron—Pain—Mycophenolate mofetil—systemic scleroderma	0.000457	0.000784	CcSEcCtD
Dolasetron—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000457	0.000784	CcSEcCtD
Dolasetron—Arrhythmia—Prednisone—systemic scleroderma	0.000456	0.000781	CcSEcCtD
Dolasetron—Haematuria—Methotrexate—systemic scleroderma	0.000453	0.000776	CcSEcCtD
Dolasetron—Hypersensitivity—Lisinopril—systemic scleroderma	0.000449	0.000771	CcSEcCtD
Dolasetron—Dizziness—Mycophenolic acid—systemic scleroderma	0.000448	0.000768	CcSEcCtD
Dolasetron—Epistaxis—Methotrexate—systemic scleroderma	0.000448	0.000768	CcSEcCtD
Dolasetron—Rash—Leflunomide—systemic scleroderma	0.000448	0.000767	CcSEcCtD
Dolasetron—Dermatitis—Leflunomide—systemic scleroderma	0.000447	0.000767	CcSEcCtD
Dolasetron—Headache—Leflunomide—systemic scleroderma	0.000445	0.000763	CcSEcCtD
Dolasetron—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00044	0.000755	CcSEcCtD
Dolasetron—Asthenia—Lisinopril—systemic scleroderma	0.000438	0.00075	CcSEcCtD
Dolasetron—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000437	0.000749	CcSEcCtD
Dolasetron—Pruritus—Lisinopril—systemic scleroderma	0.000432	0.00074	CcSEcCtD
Dolasetron—Rash—Mycophenolic acid—systemic scleroderma	0.000427	0.000732	CcSEcCtD
Dolasetron—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000427	0.000731	CcSEcCtD
Dolasetron—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000425	0.000728	CcSEcCtD
Dolasetron—Headache—Mycophenolic acid—systemic scleroderma	0.000424	0.000727	CcSEcCtD
Dolasetron—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000422	0.000724	CcSEcCtD
Dolasetron—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000422	0.000724	CcSEcCtD
Dolasetron—Diarrhoea—Lisinopril—systemic scleroderma	0.000417	0.000716	CcSEcCtD
Dolasetron—Ill-defined disorder—Prednisone—systemic scleroderma	0.000412	0.000706	CcSEcCtD
Dolasetron—Visual impairment—Methotrexate—systemic scleroderma	0.000411	0.000704	CcSEcCtD
Dolasetron—Anaemia—Prednisone—systemic scleroderma	0.00041	0.000703	CcSEcCtD
Dolasetron—Agitation—Prednisone—systemic scleroderma	0.000408	0.000699	CcSEcCtD
Dolasetron—Angioedema—Prednisone—systemic scleroderma	0.000406	0.000695	CcSEcCtD
Dolasetron—Dizziness—Lisinopril—systemic scleroderma	0.000403	0.000692	CcSEcCtD
Dolasetron—Malaise—Prednisone—systemic scleroderma	0.0004	0.000686	CcSEcCtD
Dolasetron—Vertigo—Prednisone—systemic scleroderma	0.000399	0.000684	CcSEcCtD
Dolasetron—Syncope—Prednisone—systemic scleroderma	0.000398	0.000683	CcSEcCtD
Dolasetron—Tinnitus—Methotrexate—systemic scleroderma	0.000397	0.000681	CcSEcCtD
Dolasetron—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000394	0.000675	CcSEcCtD
Dolasetron—Loss of consciousness—Prednisone—systemic scleroderma	0.00039	0.000669	CcSEcCtD
Dolasetron—Rash—Lisinopril—systemic scleroderma	0.000385	0.000659	CcSEcCtD
Dolasetron—Convulsion—Prednisone—systemic scleroderma	0.000385	0.000659	CcSEcCtD
Dolasetron—Dermatitis—Lisinopril—systemic scleroderma	0.000384	0.000659	CcSEcCtD
Dolasetron—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000383	0.000657	CcSEcCtD
Dolasetron—Hypertension—Prednisone—systemic scleroderma	0.000383	0.000657	CcSEcCtD
Dolasetron—Chills—Methotrexate—systemic scleroderma	0.000382	0.000656	CcSEcCtD
Dolasetron—Headache—Lisinopril—systemic scleroderma	0.000382	0.000655	CcSEcCtD
Dolasetron—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000378	0.000648	CcSEcCtD
Dolasetron—Myalgia—Prednisone—systemic scleroderma	0.000378	0.000648	CcSEcCtD
Dolasetron—Arthralgia—Prednisone—systemic scleroderma	0.000378	0.000648	CcSEcCtD
Dolasetron—Anxiety—Prednisone—systemic scleroderma	0.000377	0.000646	CcSEcCtD
Dolasetron—Discomfort—Prednisone—systemic scleroderma	0.000373	0.00064	CcSEcCtD
Dolasetron—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000366	0.000627	CcSEcCtD
Dolasetron—Dysgeusia—Methotrexate—systemic scleroderma	0.000363	0.000623	CcSEcCtD
Dolasetron—Oedema—Prednisone—systemic scleroderma	0.000362	0.000621	CcSEcCtD
Dolasetron—Anaphylactic shock—Prednisone—systemic scleroderma	0.000362	0.000621	CcSEcCtD
Dolasetron—Shock—Prednisone—systemic scleroderma	0.000356	0.000611	CcSEcCtD
Dolasetron—Tachycardia—Prednisone—systemic scleroderma	0.000354	0.000606	CcSEcCtD
Dolasetron—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000353	0.000606	CcSEcCtD
Dolasetron—Hyperhidrosis—Prednisone—systemic scleroderma	0.00035	0.0006	CcSEcCtD
Dolasetron—Anorexia—Prednisone—systemic scleroderma	0.000345	0.000592	CcSEcCtD
Dolasetron—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000344	0.00059	CcSEcCtD
Dolasetron—Anaemia—Methotrexate—systemic scleroderma	0.000343	0.000588	CcSEcCtD
Dolasetron—Rash—Mycophenolate mofetil—systemic scleroderma	0.000337	0.000578	CcSEcCtD
Dolasetron—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000337	0.000577	CcSEcCtD
Dolasetron—Headache—Mycophenolate mofetil—systemic scleroderma	0.000335	0.000574	CcSEcCtD
Dolasetron—Malaise—Methotrexate—systemic scleroderma	0.000335	0.000574	CcSEcCtD
Dolasetron—Vertigo—Methotrexate—systemic scleroderma	0.000333	0.000571	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00033	0.000566	CcSEcCtD
Dolasetron—Paraesthesia—Prednisone—systemic scleroderma	0.000325	0.000558	CcSEcCtD
Dolasetron—Cough—Methotrexate—systemic scleroderma	0.000324	0.000555	CcSEcCtD
Dolasetron—Convulsion—Methotrexate—systemic scleroderma	0.000321	0.000551	CcSEcCtD
Dolasetron—Dyspepsia—Prednisone—systemic scleroderma	0.000319	0.000547	CcSEcCtD
Dolasetron—Chest pain—Methotrexate—systemic scleroderma	0.000316	0.000542	CcSEcCtD
Dolasetron—Myalgia—Methotrexate—systemic scleroderma	0.000316	0.000542	CcSEcCtD
Dolasetron—Arthralgia—Methotrexate—systemic scleroderma	0.000316	0.000542	CcSEcCtD
Dolasetron—Decreased appetite—Prednisone—systemic scleroderma	0.000315	0.00054	CcSEcCtD
Dolasetron—Fatigue—Prednisone—systemic scleroderma	0.000312	0.000536	CcSEcCtD
Dolasetron—Discomfort—Methotrexate—systemic scleroderma	0.000312	0.000535	CcSEcCtD
Dolasetron—Constipation—Prednisone—systemic scleroderma	0.00031	0.000531	CcSEcCtD
Dolasetron—Confusional state—Methotrexate—systemic scleroderma	0.000305	0.000523	CcSEcCtD
Dolasetron—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000303	0.000519	CcSEcCtD
Dolasetron—Feeling abnormal—Prednisone—systemic scleroderma	0.000299	0.000512	CcSEcCtD
Dolasetron—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000296	0.000508	CcSEcCtD
Dolasetron—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000296	0.000508	CcSEcCtD
Dolasetron—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000293	0.000502	CcSEcCtD
Dolasetron—Anorexia—Methotrexate—systemic scleroderma	0.000289	0.000495	CcSEcCtD
Dolasetron—Urticaria—Prednisone—systemic scleroderma	0.000288	0.000493	CcSEcCtD
Dolasetron—Abdominal pain—Prednisone—systemic scleroderma	0.000286	0.000491	CcSEcCtD
Dolasetron—Body temperature increased—Prednisone—systemic scleroderma	0.000286	0.000491	CcSEcCtD
Dolasetron—Hypotension—Methotrexate—systemic scleroderma	0.000283	0.000485	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000276	0.000473	CcSEcCtD
Dolasetron—Paraesthesia—Methotrexate—systemic scleroderma	0.000272	0.000466	CcSEcCtD
Dolasetron—Dyspnoea—Methotrexate—systemic scleroderma	0.00027	0.000463	CcSEcCtD
Dolasetron—Somnolence—Methotrexate—systemic scleroderma	0.000269	0.000461	CcSEcCtD
Dolasetron—Hypersensitivity—Prednisone—systemic scleroderma	0.000267	0.000458	CcSEcCtD
Dolasetron—Dyspepsia—Methotrexate—systemic scleroderma	0.000266	0.000457	CcSEcCtD
Dolasetron—Decreased appetite—Methotrexate—systemic scleroderma	0.000263	0.000451	CcSEcCtD
Dolasetron—Fatigue—Methotrexate—systemic scleroderma	0.000261	0.000448	CcSEcCtD
Dolasetron—Asthenia—Prednisone—systemic scleroderma	0.00026	0.000446	CcSEcCtD
Dolasetron—Pain—Methotrexate—systemic scleroderma	0.000259	0.000444	CcSEcCtD
Dolasetron—Pruritus—Prednisone—systemic scleroderma	0.000256	0.000439	CcSEcCtD
Dolasetron—Feeling abnormal—Methotrexate—systemic scleroderma	0.000249	0.000428	CcSEcCtD
Dolasetron—Diarrhoea—Prednisone—systemic scleroderma	0.000248	0.000425	CcSEcCtD
Dolasetron—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000248	0.000424	CcSEcCtD
Dolasetron—Urticaria—Methotrexate—systemic scleroderma	0.000241	0.000412	CcSEcCtD
Dolasetron—Dizziness—Prednisone—systemic scleroderma	0.00024	0.000411	CcSEcCtD
Dolasetron—Abdominal pain—Methotrexate—systemic scleroderma	0.000239	0.00041	CcSEcCtD
Dolasetron—Body temperature increased—Methotrexate—systemic scleroderma	0.000239	0.00041	CcSEcCtD
Dolasetron—Rash—Prednisone—systemic scleroderma	0.000228	0.000392	CcSEcCtD
Dolasetron—Dermatitis—Prednisone—systemic scleroderma	0.000228	0.000391	CcSEcCtD
Dolasetron—Headache—Prednisone—systemic scleroderma	0.000227	0.000389	CcSEcCtD
Dolasetron—Hypersensitivity—Methotrexate—systemic scleroderma	0.000223	0.000382	CcSEcCtD
Dolasetron—Asthenia—Methotrexate—systemic scleroderma	0.000217	0.000372	CcSEcCtD
Dolasetron—Pruritus—Methotrexate—systemic scleroderma	0.000214	0.000367	CcSEcCtD
Dolasetron—Diarrhoea—Methotrexate—systemic scleroderma	0.000207	0.000355	CcSEcCtD
Dolasetron—Dizziness—Methotrexate—systemic scleroderma	0.0002	0.000343	CcSEcCtD
Dolasetron—Rash—Methotrexate—systemic scleroderma	0.000191	0.000327	CcSEcCtD
Dolasetron—Dermatitis—Methotrexate—systemic scleroderma	0.000191	0.000327	CcSEcCtD
Dolasetron—Headache—Methotrexate—systemic scleroderma	0.00019	0.000325	CcSEcCtD
